Family Medicine · Shipshewana, IN
NPI
1982675864
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
450 E Country Ln
Shipshewana, IN, 46565
Phone (260) 768-4141
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
2,980 services
Medicare patients, 2024
347
Average age 77
Drug cost, 2024
$1.5M
17,171 prescriptions
Company payments, 2025
$362
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas A Pechin II was code 99308 (snf e&m), 386 times for 103 patients. In total Thomas A Pechin II billed 2,980 services in 85 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 386 | 103 | $54.02 | $21K |
| 99214 Office E&M - Established | Office | 305 | 147 | $71.54 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 264 | 141 | $10.90 | $2,876 |
| 99307 SNF E&M | Office | 241 | 89 | $28.09 | $6,769 |
| 99213 Office E&M - Established | Office | 187 | 118 | $54.54 | $10K |
| 36415 Venipuncture Blood Collection | Office | 177 | 111 | $8.65 | $1,531 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 110 | 22 | $45.54 | $5,010 |
| 99309 SNF E&M | Office | 90 | 51 | $78.54 | $7,068 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 83 | 83 | $120.47 | $9,999 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 76 | 19 | $34.95 | $2,656 |
| 99305 SNF E&M | Office | 53 | 46 | $98.38 | $5,214 |
| G0008 Administration of influenza virus vaccine | Office | 37 | 36 | $30.10 | $1,114 |
| 83036 Blood Count | Office | 36 | 30 | $9.52 | $343 |
| 90662 Vaccine Product | Office | 35 | 34 | $81.54 | $2,854 |
| 20610 Joint Injection | Office | 20 | 13 | $33.10 | $662 |
By year: 2022 $87K for 2,032 services; 2023 $92K for 2,008 services; 2024 $111K for 2,980 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 177 | 111 | $8.65 | $1,531 |
| 83036 Blood Count | 36 | 30 | $9.52 | $343 |
| 81003 Clinical Chemistry | 15 | 13 | $2.20 | $33 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas A Pechin II prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,133 prescriptions and refills. In total Thomas A Pechin II wrote 17,171 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,133 | 2,229 | 246 | $14K |
| Levothyroxine Sodium Generic | 679 | 1,102 | 122 | $9,602 |
| Eliquis Apixaban | 565 | 653 | 64 | $231K |
| Amlodipine Besylate Generic | 464 | 1,015 | 116 | $4,027 |
| Furosemide Generic | 434 | 527 | 66 | $3,395 |
| Metformin Hcl Generic | 406 | 817 | 83 | $3,565 |
| Sertraline Hcl Generic | 400 | 501 | 64 | $6,583 |
| Gabapentin Generic | 399 | 512 | 66 | $7,672 |
| Lisinopril Generic | 386 | 804 | 84 | $3,706 |
| Metoprolol Succinate Generic | 362 | 595 | 74 | $5,358 |
| Losartan Potassium Generic | 314 | 574 | 73 | $4,079 |
| Omeprazole Generic | 303 | 548 | 70 | $4,013 |
| Tamsulosin Hcl Generic | 300 | 461 | 55 | $6,345 |
| Pantoprazole Sodium Generic | 281 | 399 | 66 | $4,941 |
| Carvedilol Generic | 275 | 394 | 52 | $4,000 |
Brand drugs: 2,849 claims; generic drugs: 14,087 claims; opioid claims: 276.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas A Pechin II $362 ($362 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $56.6.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56.6 |
| Lundbeck LLC | 2 | $55.37 |
| Pfizer Inc. PFE | 3 | $50.42 |
| Exact Sciences Corporation EXAS | 2 | $40.97 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $37.41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $35.7 |
| Lilly USA, LLC LLY | 2 | $31.53 |
| Abbvie Inc. ABBV | 1 | $20.52 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $15.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.